Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial

Fig. 2

Primary cognitive outcomes in dabigatran and warfarin groups. There were no significant differences between dabigatran and warfarin treatment groups for most of the cognitive tests at 2 years (except for MoCA) in comparison to baseline. Comparison between D and W groups for the four tests that represent the primary cognitive outcomes. Differences between groups (95% CI) are expressed in the adjusted mean change from baseline (points) and 95% confidence intervals (segments) for the four primary outcomes

Back to article page